Cumulative oral corticosteroid use increases risk of glucocorticoid-related adverse events in patients with newly diagnosed pemphigus-Reference-Cited by-同舟云学术

Cumulative oral corticosteroid use increases risk of glucocorticoid-related adverse events in patients with newly diagnosed pemphigus

Published:2017-08 Issue:2 Volume:77 Page:379-381
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Wormser David,Chen Diana M.,Brunetta Paul G.,Sun Diana,Broder Michael S.,Chang Eunice,Reddy Sheila R.

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. US Food and Drug Administration. Highlights of Prescribing Information for RAYOS (Prednisone). 2012. Available from: URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202020s000lbl.pdf.

2. Pemphigus vulgaris: a review of treatment over a 19-year period;Ljubojević;J Eur Acad Dermatol Venereol,2002

3. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies;Anderson;Int J Cancer,2009

4. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis;Miloslavsky;Ann Rheum Dis,2017

5. Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review;Sarnes;Clin Ther,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upadacitinib leading to resolution of refractory mucosal erosions in a case of pemphigus vulgaris;International Journal of Dermatology;2024-08-29

2. Dose-Adjusted FRAX Score in Pemphigus Vulgaris Treatment;Indian Journal of Dermatology;2023-11

3. Evaluation of clinical factors and outcome of systemic glucocorticoid therapy discontinuation in patients with pemphigus achieving complete remission;The Journal of Dermatology;2023-05-30

4. Pemphigus for the Inpatient Dermatologist;Current Dermatology Reports;2022-09-02

5. Evaluation of non-endemic pemphigus foliaceus in a large series of patients: a single-center retrospective study from Turkey focuses on the relapses;Anais Brasileiros de Dermatologia;2021-07